- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Environmentally-Friendly
Global Pharmaceuticals & Biotech Environmentally-Friendly
UPDATED Jun 15, 2024
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
3,251 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
300896 | CN¥185.89 | -7.1% | -43.6% | CN¥55.9b | CN¥307.52 | PE28.4x | E25.2% | 1.8% | ||
CALTX | kr205.40 | -1.3% | 114.6% | kr11.0b | kr221.25 | PS8.4x | E52.9% | n/a | ||
NEWBRY | kr3.22 | 0% | -21.1% | kr78.1m | kr8.00 | PS3.4x | E112.9% | n/a | ||
ADOC | €7.37 | -13.9% | n/a | €108.6m | €9.70 | PS17.9x | E104.5% | n/a | ||
AXSM | US$73.63 | -0.4% | -13.4% | US$3.5b | US$123.75 | PS13.9x | E64.1% | n/a | ||
TGTX | US$16.55 | 4.4% | -35.5% | US$2.4b | US$31.50 | PE57.5x | E48.0% | n/a | ||
OSE | €6.29 | -19.9% | 80.2% | €136.5m | €7.15 | PS61.3x | E79.3% | n/a | ||
CLBIO | kr12.35 | 12.3% | -19.5% | kr265.4m | kr29.00 | PS8.6x | E114.8% | n/a | ||
CAMX | kr545.50 | -8.9% | 92.6% | kr31.6b | kr621.50 | PE70.2x | E55.7% | n/a | ||
ORCHPHARMA | ₹1,057.80 | -1.4% | 149.0% | ₹53.7b | ₹1,252.33 | PE58.2x | E42.4% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | ||
A196170 | ₩265,000.00 | -1.5% | 507.8% | ₩14.1t | ₩201,250.00 | PE551.2x | E73.1% | n/a | ||
ACR | AU$0.077 | 1.3% | 67.4% | AU$22.4m | n/a | PS2x | E115.3% | 0% | ||
BLUEJET | ₹391.95 | 1.7% | n/a | ₹68.0b | ₹406.67 | PE41.5x | E22.6% | 0.3% | ||
XBRANE | kr0.29 | -10.4% | -99.6% | kr441.3m | n/a | PS2.3x | E105.2% | n/a | ||
BONEX | kr252.00 | 1.6% | 107.7% | kr16.6b | kr297.67 | PE62.1x | E22.1% | n/a | ||
A326030 | ₩78,300.00 | -9.2% | -8.7% | ₩6.1t | ₩107,250.00 | PS15x | E85.3% | n/a | ||
IVVD | US$1.58 | -6.5% | 28.5% | US$188.5m | US$9.23 | PB1.1x | E69.8% | n/a | ||
ALDVI | €1.97 | -21.7% | -50.2% | €24.2m | €6.90 | PS7.4x | E118.1% | n/a | ||
688177 | CN¥24.95 | 0.2% | -5.4% | CN¥10.3b | CN¥42.10 | PS14.5x | E105.4% | n/a | ||
603392 | CN¥66.75 | 0.3% | -1.2% | CN¥84.7b | CN¥70.40 | PE658.9x | E63.0% | 0.5% | ||
BOT | AU$0.33 | 20.0% | 200.0% | AU$519.8m | n/a | PS1188.9x | E120.9% | n/a | ||
BIOA B | kr226.60 | -4.6% | -34.5% | kr20.0b | kr368.00 | PS79.4x | E50.9% | 0% |